Tech Channel Mongolia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Channel Mongolia.

Press releases published on March 30, 2026

Mar. 30, 2026

Teva gewinnt an Dynamik im Biosimilar-Geschäft mit der FDA-Zulassung für PONLIMSI™ (Denosumab-adet) und der Annahme von parallelen Zulassungsanträgen für einen Biosimilar-Kandidaten zu Xolair® (Omalizumab)

Indeterminate GlobeNewswire

Mar. 30, 2026

Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab)

Indeterminate GlobeNewswire

Mar. 30, 2026

Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress

Indeterminate GlobeNewswire

Mar. 30, 2026

Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

Indeterminate GlobeNewswire

Mar. 30, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 30, 2026

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

Indeterminate GlobeNewswire

Mar. 30, 2026

Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease

Indeterminate GlobeNewswire

Mar. 30, 2026

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

Indeterminate GlobeNewswire

Mar. 30, 2026

Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI

Indeterminate GlobeNewswire

Mar. 30, 2026

VisionWave Provides Corporate Update on Planned Expansion of Multi-Domain Intelligence Platform Across Defense, Energy, and Autonomous Systems

Indeterminate GlobeNewswire

Mar. 30, 2026

electroCore Expands Intellectual Property Portfolio

Indeterminate GlobeNewswire

Mar. 30, 2026

Lianhe Sowell International Group Ltd. Announces $1.8 Million Contract to Develop AI Steam Car‑Wash Robot Promising Significant Water Savings

Indeterminate GlobeNewswire

Mar. 30, 2026

Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial

Indeterminate GlobeNewswire

Mar. 30, 2026

Sagtec Global (NASDAQ: SAGT) to Launch Sovereign AI Data Center Powered by NVIDIA GPU Architecture; Infrastructure Pivot to Support Millions of Daily F&B Retail Ordering, Retail and Fintech Transactions

Indeterminate GlobeNewswire

Mar. 30, 2026

NowVertical Signs $3.8 Million 2026 Expansion with Global Events Enterprise, Surpassing $26 Million in Cumulative Account Value

Indeterminate GlobeNewswire

Mar. 30, 2026

Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale

Indeterminate GlobeNewswire

Mar. 30, 2026

Nano Labs Announces Second Half of 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

SEALSQ joins ECHONET Consortium as PKI Services provider to Strengthen IoT Security in Smart Home and Energy Networks in Japan

Indeterminate GlobeNewswire

Mar. 30, 2026

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Indeterminate GlobeNewswire

Mar. 30, 2026

Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates

Indeterminate GlobeNewswire